RT @StJudeResearch: Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @…
RT @StJudeResearch: Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @…
RT @StJudeResearch: Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @…
RT @StJudeResearch: Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @…
RT @StJudeResearch: Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @…
RT @StJudeResearch: Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @…
RT @StJudeResearch: Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @…
RT @StJudeResearch: Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @…
RT @StJudeResearch: Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @…
RT @StJudeResearch: Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @…
RT @StJudeResearch: Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @…
RT @StJudeResearch: Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @…
Scientists at St. Jude and @DanaFarber have created a compound to selectively target EP300 in neuroblastoma. Read the @CD_AACR paper. https://t.co/PLlklVzrD6 @ADurbinLab https://t.co/lRYqkyXgKc
RT @AlexsLemonade: Congratulations to @junqilab and @ADurbinLab for this exciting development in the fight against neuroblastoma. #AlexsLe…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @MilkaKostic: CBP/P300 are two VERY closely related transcriptional co-activators, and current inhibitors have dual activity on both. @J…
CBP/P300 are two VERY closely related transcriptional co-activators, and current inhibitors have dual activity on both. @JunQiLab, in collaboration with @ADurbinLab, @DocWang4 and @KStegmaier_DFCI, describe development and characterization of selective P30
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
Cool therapeutic strategy!
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @AlexsLemonade: Congratulations to @junqilab and @ADurbinLab for this exciting development in the fight against neuroblastoma. #AlexsLe…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
RT @JunQiLab: We really appreciate @AACR journals that accepted and published our KDM5 story @BCD_AACR @_TanyaBondar_ and EP300 story @CD_…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
Congrats Adam!
RT @AlexsLemonade: Congratulations to @junqilab and @ADurbinLab for this exciting development in the fight against neuroblastoma. #AlexsLe…
Congratulations to @junqilab and @ADurbinLab for this exciting development in the fight against neuroblastoma. #AlexsLemonade is proud to have supported this research through a Young Investigator Grant and an Innovation Grant.
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
RT @ADurbinLab: Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy fo…
Targeting EP300 selectively...a tweetorial! 1/x Live now @CD_AACR, our most recent manuscript detailing our new strategy for targeting neuroblastoma! https://t.co/x1fxcERtfi Here, by a cross-institution collaboration, we generated a beautiful new chemical
pretty proud of this one from my work as a tech :’)
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @JunQiLab: We really appreciate @AACR journals that accepted and published our KDM5 story @BCD_AACR @_TanyaBondar_ and EP300 story @CD_…
RT @JunQiLab: We really appreciate @AACR journals that accepted and published our KDM5 story @BCD_AACR @_TanyaBondar_ and EP300 story @CD_…
RT @JunQiLab: We really appreciate @AACR journals that accepted and published our KDM5 story @BCD_AACR @_TanyaBondar_ and EP300 story @CD_…
We really appreciate @AACR journals that accepted and published our KDM5 story @BCD_AACR @_TanyaBondar_ and EP300 story @CD_AACR https://t.co/VAGu97c3Q0 https://t.co/naRJ2BGvCG
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
Check out this great work taking down epigenetic proteins with surgical precision!
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
RT @JunQiLab: our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really…
our manuscript is now online. Congratulations to all the team members!!! @ADurbinLab @DocWang4 @KStegmaier_DFCI . We really appreciate the support from @CD_AACR. Thanks @AlexsLemonade for support. https://t.co/naRJ2BGvCG